Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TACT IP LLC v. Janssen Biotech, Inc. et al
Case Number:
1:12-cv-00909
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 19, 2013
Va. Court Urged To Reverse USPTO Neurological Patent Ruling
A Virginia magistrate judge on Friday recommended that a U.S. Patent and Trademark Office appeal board decision rejecting Tact IP LLC's bid to claim priority for patents covering treatment for neurological conditions should be reversed, saying the disputed methods are novel and nonobvious.
-
August 16, 2012
Janssen Biotech, NYU Sued Over Neuro Treatment Patents
Tact IP LLC on Wednesday filed a suit against Janssen Biotech Inc. and New York University that sought to overturn a recent U.S. Patent and Trademark Office appeal board decision that rejected Tact's bid to claim priority for patents covering treatment for neurological conditions.